Wuxi Hyatech Co

Wuxi Hyatech Co EBITDA per Share

The EBITDA per Share of Wuxi Hyatech Co (688510.SS) as of Oct 22, 2026 is 0.46 CNY. In the previous year, EBITDA per Share was 0.55 CNY — a change of -17.39% (lower).

EBITDA per Share

0.46CNY

YoY

-17.39%

Last updated:

EBITDA per Share of Wuxi Hyatech Co is 2025 0.46 CNY. EBITDA per Share of Wuxi Hyatech Co was 2024 0.55 CNY. It decreases by -17.39% lower compared to the previous year.

The Wuxi Hyatech Co EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2018
0.08 CNY
Jan 1, 2019
0.25 CNY
Jan 1, 2020
0.38 CNY
Jan 1, 2021
0.09 CNY
Jan 1, 2022
0.09 CNY
Jan 1, 2023
0.39 CNY
Jan 1, 2024
0.55 CNY
Jan 1, 2025
0.46 CNY
The Wuxi Hyatech Co EBITDA per Share history
YEAREBITDA per ShareYoY
0.46CNY-17.39%
0.55CNY+40.21%
0.39CNY+347.18%
0.09CNY+3.53%
0.09CNY-77.31%
0.38CNY+51.11%
0.25CNY+228.84%
0.08CNY-329.10%
-0.03CNY-84.23%
-0.21CNY+140.21%
-0.09CNY+16.20%
-0.07CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Wuxi Hyatech Co Stock analysis

What does Wuxi Hyatech Co do? Wuxi Hyatech Co Ltd generates revenue through the research and development, manufacturing, and sales of key components for aero-engines and medical orthopedic implant forgings. The company produces high-performance components including aviation turbofan engine compressor blades, rotating parts, and structural parts, which are sold domestically and internationally. Its primary customers are aerospace manufacturers and medical device companies requiring specialized forgings for engine parts and orthopedic implants. The firm targets the aerospace and medical sectors with its focus on precision-engineered components for critical applications. The company's product portfolio includes aviation turbofan engine compressor blades, rotating parts, and structural parts, alongside medical orthopedic implant forgings. These products are distributed across domestic and overseas markets, serving both the Chinese aerospace industry and international medical device markets. Wuxi Hyatech's revenue streams are derived from direct sales of these specialized components to industrial and medical clients without third-party intermediaries. Wuxi Hyatech's business model centers on supplying high-precision components for aero-engines and medical orthopedic implants. The company's manufacturing capabilities enable it to produce critical parts for aircraft engines and orthopedic devices, with a focus on domestic and international industrial clients. Revenue is generated through the sale of these specialized forgings to aerospace and medical sectors, leveraging its R&D expertise in component production. Wuxi Hyatech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Wuxi Hyatech Co stock

EBITDA per Share of Wuxi Hyatech Co is 0.46 CNY in 2025.

EBITDA per Share of Wuxi Hyatech Co changed from 0.55 CNY to 0.46 CNY, representing a -17.39% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Wuxi Hyatech Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Wuxi Hyatech Co

All Key Metrics — Wuxi Hyatech Co